Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.44 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560358 | 0.81 | ALDH1A1 (0.42) | ALDH1A1HPGDCALM1 | |
| SCHEMBL27950339 | 0.79 | EED (0.50) | IDO1ALDH1A1 | |
| SCHEMBL28335303 | 0.78 | PKM (0.49) | GLANPSR1IDO1ALDH1A1MAPT | |
| SCHEMBL4821864 | 0.78 | PKM (0.49) | GLANPSR1IDO1ALDH1A1MAPT | |
| SCHEMBL29911017 | 0.78 | LPL (0.40) | SMN1; SMN2IDO1ALDH1A1 | |
| SCHEMBL21154704 | 0.78 | ALDH1A1 (0.40) | NPSR1SMN1; SMN2IDO1ALDH1A1HPGD | |
| SCHEMBL9840578 | 0.77 | PKM (0.51) | ALDH1A1GAAMAPTHPGD | |
| SCHEMBL29910924 | 0.77 | CA2 (0.58) | — | |
| SCHEMBL21155257 | 0.75 | ESR1 (0.44) | IDO1ALDH1A1 | |
| SCHEMBL14166113 | 0.75 | TSHR (0.39) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115010693-A | Preparation method of aryl acetaldehyde aldehyde | 长沙资材科技有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-103562198-A | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | CHIESI FARMA SPA | 2014-02-05 | — | — | CN | disclosed |
| EP-2215099-A1 | PROBE FOR MEASURING PHYTASE ACTIVITY | Berry & Associates , Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| US-7741506-B2 | Probe for measuring phytase activity | BERRY & ASSOCIATES, INC. (US) | 2010-06-22 | — | — | US | disclosed |
| US-20100048802-A1 | TRIPHENYL MONOMERS SUITABLE FOR MICROSTRUCTURED OPTICAL FILMS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-25 | — | — | US | disclosed |
| WO-2009061393-A1 | PROBE FOR MEASURING PHYTASE ACTIVITY | BERRY & ASSOCIATES, INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20080132713-A1 | Probe for measuring phytase activity | BERRY & ASSOCIATES, INC. | 2008-06-05 | — | — | US | disclosed |
| US-20060241308-A1 | Probe for measuring phytase activity | BERRY & ASSOCIATES, INC. | 2006-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132713-A1 | Probe for measuring phytase activity | IP6K3, HRH3, DNPH1 | GLA 315/4885NPSR1 3872/4885SMN1; SMN2 3724/4885 |
| US-20060241308-A1 | Probe for measuring phytase activity | IP6K3, PHYKPL, IP6K2 | GLA 498/4885NPSR1 3351/4885SMN1; SMN2 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.